Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Ventana Medical Systems, Inc., acquired by Roche in 2008, is a global leader in the development, manufacturing, and commercialization of instrument and reagent systems for automating tissue-based cancer diagnostics. Their solutions are pivotal in anatomical pathology, helping clinicians make accurate and timely diagnoses to guide treatment decisions, particularly in oncology. Ventana's innovations are now integral to Roche Tissue Diagnostics, enhancing Roche's leadership in in-vitro diagnostics and personalized healthcare.
Serves as the global headquarters for Roche Tissue Diagnostics, encompassing research and development, manufacturing, commercial operations, and customer support for tissue-based diagnostic solutions.
State-of-the-art R&D laboratories, advanced manufacturing facilities for diagnostic instruments and reagents, and a campus designed to foster collaboration and innovation in cancer diagnostics.
As part of Roche, the Tucson site embodies a culture focused on scientific innovation, patient impact, quality, and collaboration. Employees are driven by the mission to improve patient lives through advanced diagnostics.
The Tucson campus is crucial for Roche's global leadership in oncology diagnostics, housing the core expertise and infrastructure from the original Ventana Medical Systems. It continues to be a hub for pioneering advancements in tissue diagnostics.
Through Roche's extensive global network, the technologies and products originating from Ventana Medical Systems are available in over 150 countries worldwide. Roche Diagnostics provides comprehensive global support including sales, customer service, technical assistance, R&D collaborations, and clinical trial support across North America, Europe, Asia-Pacific, Latin America, and the Middle East/Africa. This ensures broad access to advanced tissue diagnostic solutions for cancer care globally.
1910 E Innovation Park Dr
Tucson
Arizona
USA
Address: Grenzacherstrasse 124, 4070 Basel, Switzerland
Central hub for global strategy, corporate governance, and allocation of resources across Roche's worldwide operations.
Address: 9115 Hague Rd, Indianapolis, IN 46256, USA
Key operational center for Roche Diagnostics in North America, facilitating logistics, sales, and service for a broad range of diagnostic solutions.
Address: Sandhofer Strasse 116, 68305 Mannheim, Germany
Major European hub for Roche Diagnostics, playing a critical role in product development, manufacturing, and distribution across the EMEA region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ventana Medical Systems' leadership includes:
Ventana Medical Systems has been backed by several prominent investors over the years, including:
As Ventana is fully integrated into Roche, executive changes are typically announced at the Roche Diagnostics or Roche Group level. While routine leadership transitions may occur, no high-profile executive hires or exits directly and exclusively impacting the top leadership of the Roche Tissue Diagnostics division (the successor to Ventana) have been prominently publicized in general news within the immediate past 12 months. Key leadership like the Head of Roche Tissue Diagnostics has been stable.
Discover the tools Ventana Medical Systems uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Employees of Ventana Medical Systems, now part of Roche, use Roche's standardized corporate email format. The most common format is firstname.lastname@roche.com.
firstname.lastname@roche.com
Format
john.doe@roche.com
Example
95%
Success rate
Roche.com News • February 1, 2024
Roche announced the launch of two new CE-IVD marked AI-powered image analysis algorithms, uPath HER2 (4B5) image analysis and uPath Ki-67 (30-9) image analysis for breast cancer. These algorithms, integrated with Roche's uPath enterprise software, aim to help pathologists more accurately and efficiently assess stained tissue samples, building upon the innovations from Ventana....more
Roche.com News • July 13, 2023
Roche announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VENTANA DP 600 slide scanner. This high-speed, high-capacity slide scanner produces excellent quality images for digital pathology, enhancing diagnostic capabilities, particularly in oncology....more
Roche.com News • March 7, 2023
Roche announced the launch of the VENTANA DP 600 (20-slide) slide scanner. This new addition to Roche's digital pathology portfolio, which builds on Ventana's legacy, offers high-speed scanning and image quality to help laboratories accelerate the adoption of digital pathology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ventana Medical Systems, are just a search away.